Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.
Wioleta M ZelekJade ColeMark J PonsfordRichard A HarrisonBen E SchroederNicholas WebbStephen R A JollesChristopher FeganMatt MorganMatt P WiseB Paul MorganPublished in: American journal of respiratory and critical care medicine (2020)